Among the four members of HMGB, HMGB1 is considered as a potential therapeutic target for sepsis, and glycyrrhizin protects rats from sepsis-induced damage by preventing the HMGB1-mediated inflammation [18]. The gene discussed is HMGB1; the disease is Sepsis.